{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:57:58Z","timestamp":1778914678658,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.taap.2017.06.015","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T04:01:37Z","timestamp":1497585697000},"page":"282-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway"],"prefix":"10.1016","volume":"329","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2553-3076","authenticated-orcid":false,"given":"Takayuki","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Uesugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.06.015_bb0005","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1074\/jbc.274.8.5038","article-title":"Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1\/2-mediated induction of cyclooxygenase-2","volume":"274","author":"Adderley","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.06.015_bb0010","doi-asserted-by":"crossref","first-page":"25464","DOI":"10.1074\/jbc.M703663200","article-title":"siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy","volume":"282","author":"Chan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2017.06.015_bb0015","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2017.06.015_bb0020","doi-asserted-by":"crossref","first-page":"E2253","DOI":"10.1073\/pnas.1416230112","article-title":"Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia\/reperfusion injury","volume":"112","author":"Chung","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2017.06.015_bb0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2011.08.020","article-title":"Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations","volume":"257","author":"Cohen","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.06.015_bb0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/bjc.2016.294","article-title":"Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib","volume":"115","author":"Courtin","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2017.06.015_bb0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7164\/antibiotics.23.442","article-title":"Geldanamycin, a new antibiotic","volume":"23","author":"DeBoer","year":"1970","journal-title":"J. Antibiot."},{"key":"10.1016\/j.taap.2017.06.015_bb0040","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.taap.2017.06.015_bb0045","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.cdd.4401812","article-title":"Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection","volume":"13","author":"Demidenko","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2017.06.015_bb0050","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-16-0132-T","article-title":"Autophagy inhibition enhances sunitinib efficacy in clear cell ovarian carcinoma","author":"DeVorkin","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.taap.2013.04.027","article-title":"Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes","volume":"272","author":"Doherty","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.06.015_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","article-title":"AMPK alterations in cardiac physiology and pathology: enemy or ally?","volume":"574","author":"Dyck","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.taap.2017.06.015_bb0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nbt1068","article-title":"A small molecule-kinase interaction map for clinical kinase inhibitors","volume":"23","author":"Fabian","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.taap.2017.06.015_bb0070","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2017.06.015_bb0075","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1158\/1078-0432.CCR-11-0562","article-title":"The novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations","volume":"17","author":"Floris","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0080","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S1470-2045(13)70169-4","article-title":"Inhibition of HSP90 molecular chaperones: moving into the clinic","volume":"14","author":"Garcia-Carbonero","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2017.06.015_bb0085","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1158\/1078-0432.CCR-11-1667","article-title":"Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance","volume":"17","author":"Gotink","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0090","doi-asserted-by":"crossref","first-page":"H1081","DOI":"10.1152\/ajpheart.00921.2003","article-title":"Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes","volume":"287","author":"Griffin","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2017.06.015_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10565-011-9202-x","article-title":"Mitigation of H2O2-induced autophagic cell death by propofol in H9c2 cardiomyocytes","volume":"28","author":"Ha","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.taap.2017.06.015_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.taap.2009.12.032","article-title":"The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity","volume":"244","author":"Hasinoff","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.06.015_bb0105","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1124\/mol.108.050104","article-title":"Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib","volume":"74","author":"Hasinoff","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2017.06.015_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1254\/jphs.12158FP","article-title":"Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells","volume":"121","author":"Ikeda","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2017.06.015_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1752-8062.2008.00090.x","article-title":"Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase","volume":"2","author":"Kerkela","year":"2009","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.taap.2017.06.015_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvr071","article-title":"Glucose metabolism and cardiac hypertrophy","volume":"90","author":"Kolwicz","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI73943","article-title":"Autophagy in cardiovascular biology","volume":"125","author":"Lavandero","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2017.06.015_bb0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3858\/emm.2010.42.10.069","article-title":"Heat shock protein 90 regulates I\u03baB kinase complex and NF-\u03baB activation in angiotensin II-induced cardiac cell hypertrophy","volume":"42","author":"Lee","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.taap.2017.06.015_bb0135","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ijc.28261","article-title":"Molecular-targeted agents combination therapy for cancer: developments and potentials","volume":"134","author":"Li","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2017.06.015_bb0140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2015.05.042","article-title":"Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK","volume":"463","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2017.06.015_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2017.06.015_bb0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3892\/ijmm.2015.2291","article-title":"Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway","volume":"36","author":"Lou","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.taap.2017.06.015_bb0155","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2017.06.015_bb0160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Mizushima","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2017.06.015_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.taap.2017.06.015_bb0170","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118468","article-title":"Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression?","volume":"97","author":"Morris","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2017.06.015_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2017.06.015_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12192-014-0509-4","article-title":"Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice","volume":"19","author":"Naka","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.taap.2017.06.015_bb0185","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm1574","article-title":"The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress","volume":"13","author":"Nakai","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2017.06.015_bb0190","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2017.06.015_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/toxsci\/kfs233","article-title":"Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening","volume":"130","author":"Rana","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2017.06.015_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1007066903073","article-title":"Differential effects of chloroquine on cardiolipin biosynthesis in hepatocytes and H9c2 cardiac cells","volume":"207","author":"Ross","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2017.06.015_bb0205","doi-asserted-by":"crossref","first-page":"E615","DOI":"10.1152\/ajpendo.00035.2011","article-title":"Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2\/Akt\/mTOR\/S6K1 pathways through modulation of Bcl-2 and BAD","volume":"302","author":"Saito","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2017.06.015_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","article-title":"The RIN: an RNA integrity number for assigning integrity values to RNA measurements","volume":"7","author":"Schroeder","year":"2006","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.taap.2017.06.015_bb0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","article-title":"Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent","volume":"89","author":"Stebbins","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.taap.2017.06.015_bb0220","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-13-0965","article-title":"Geranylgeranylacetone blocks doxorubicin-induced cardiac toxicity and reduces cancer cell growth and invasion through RHO pathway inhibition","volume":"13","author":"Sysa-Shah","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2017.06.015_bb0225","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cvr\/cvu049","article-title":"Keep your heart in shape: molecular chaperone networks for treating heart disease","volume":"102","author":"Tarone","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0230","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.1128\/MCB.25.21.9554-9575.2005","article-title":"AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress","volume":"25","author":"Terai","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2017.06.015_bb0235","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vascn.2013.11.002","article-title":"Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes","volume":"69","author":"Uesugi","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.taap.2017.06.015_bb0240","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1158\/1078-0432.CCR-10-0503","article-title":"Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin","volume":"16","author":"Vaishampayan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1379\/1466-1268(1998)003<0221:HSPCLA>2.3.CO;2","article-title":"Heat shock proteins chaperoning life and death","volume":"3","author":"Vayssier","year":"1998","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.taap.2017.06.015_bb0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/toxsci\/kfn157","article-title":"Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells","volume":"106","author":"Will","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2017.06.015_bb0255","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1096\/fj.10-167676","article-title":"Functional interaction of heat shock protein 90 and Beclin 1 modulates toll-like receptor-mediated autophagy","volume":"25","author":"Xu","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2017.06.015_bb0260","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/1535-7163.MCT-11-0755","article-title":"Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy","volume":"11","author":"Ying","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2017.06.015_bb0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11010-012-1265-3","article-title":"Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia\/reoxygenation","volume":"365","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.taap.2017.06.015_bb0270","first-page":"2862","article-title":"Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.taap.2017.06.015_bb0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.taap.2010.07.007","article-title":"Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells","volume":"248","author":"Zhao","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.06.015_bb0280","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2144\/000112536","article-title":"In-Fusion\u2122 assembly: seamless engineering of multidomain fusion proteins, modular vectors, and mutations","volume":"43","author":"Zhu","year":"2007","journal-title":"BioTechniques"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17302715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17302715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T04:36:24Z","timestamp":1575520584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17302715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":56,"alternative-id":["S0041008X17302715"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.06.015","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}